INSM
Insmed Incorporated
NASDAQ · Healthcare · Biotechnology · US
$126.29
−0.31%Leverage
- Debt / equity
- 0.77x
- Net debt / equity
- 0.05x
- Debt / assets
- 0.28x
- Debt / EBITDA
- -0.75x
- Net debt / EBITDA
- -0.05x
Liquidity & coverage
- Current ratio
- 3.72x
- Quick ratio
- 3.40x
- Cash ratio
- 2.64x
- Interest coverage
- -10.05x
- EBITDA / interest
- -9.47x
- Working capital
- $1.2B
Cash & dividend
- FCF / debt
- -1.44x
- Cash flow / debt
- -1.34x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026